Biopro

Quick links to important sections

Biopro

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Biopro

Quick Facts Description
Active Ingredients Cefadroxil, Lactobacillus, Lactobacillus acidophilus
Form Oral Capsule
Pharmacological Class First-Generation Cephalosporin Antibiotic combined with Probiotic Agent
Common Use Treating bacterial infections while supporting gut microflora
Origin Semisynthetic (Cefadroxil) and Natural (Probiotics)

Biopro: Definition, Class, and Composition

Biopro is a prescription-only combination medicine supplied as an oral capsule that integrates two active components from fundamentally distinct therapeutic classes. This formulation combines the semisynthetic antibacterial agent Cefadroxil with the probiotics Lactobacillus and Lactobacillus acidophilus. Cefadroxil belongs to the first-generation cephalosporin antibiotics, a class of antimicrobials clinically recognized for its bactericidal action. The Lactobacillus species, conversely, are categorized as live microorganisms intended to confer a general health benefit to the host. Biopro's classification as a combination product, typically targeting adult patients for general systemic use, is defined by this dual composition, necessitating a prescription due to the antibiotic component.

The Unique Combination and General Purpose

The unique design of Biopro aims to provide effective control over bacterial pathogens while simultaneously supporting the body's natural internal balance. The antibiotic, Cefadroxil, achieves bactericidal action by interfering with the formation of the bacterial cell wall, eliminating the infectious organisms. This specific combination is often utilized in situations requiring oral antibiotic clearance of infection, such as specific skin and soft tissue conditions. The concurrent inclusion of the probiotic organisms is supported by pharmacological studies indicating their role in assisting to mitigate the microbial disruption that often occurs in the digestive tract when a broad-spectrum antibiotic is taken. The combination is designed as an integrated therapeutic strategy, providing a purposeful approach to treating the infection and supporting the overall health of the gut microenvironment.

Regulatory References

  1. NIH Drug Information Portal
  2. WHO/FAO Guidelines for the Evaluation of Probiotics in Food

What side effects are possible with Biopro?

Possible Side Effects and Safety Information

The regulatory documentation for Biopro, focusing on the antibiotic component Cefadroxil, classifies adverse effects based on frequency and affected physiological systems. This profile reflects the documented safety characteristics of the combination product.

Common and Less Common Documented Reactions

Adverse reactions classified as common (occurring in ge 1/100 to < 1/10 patients) are predominantly Gastrointestinal disorders and Skin and subcutaneous tissue disorders. These may include nausea, vomiting, diarrhoea, abdominal pain, dyspepsia (indigestion), rash, pruritus (itching), and urticaria (hives). Reactions categorized as uncommon include superinfections such as vaginal mycoses or thrush, resulting from the overgrowth of nonsusceptible organisms during antibiotic exposure.


Serious Adverse Reactions and Safety Constraints

The most serious, though very rare (< 1/10,000), immediate reaction documented is the potential for anaphylactic shock. The use of the antibacterial component is also associated with Pseudomembranous colitis, which may range in severity and can occur even after cessation of therapy. Rare adverse effects across other systems include changes to the Blood and lymphatic system (e.g., leucopenia) and Renal and urinary disorders (e.g., interstitial nephritis).

Safety-related constraints require caution in patients with markedly impaired renal function, as the antibiotic is primarily eliminated by the kidneys. Furthermore, the medicine is formally contraindicated in individuals with known hypersensitivity to cephalosporins or related beta-lactam antibiotics. Prolonged use is a documented risk factor for microbial overgrowth and superinfection.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines critical information about recognizing an overdose or other serious health event and when immediate medical attention is required. Signs of an overdose or life-threatening complication are medical emergencies that require prompt action.

Immediate Emergency Action Required

Call 911 or your local emergency services immediately if any of the following symptoms occur after taking this medication:

  • Severe or prolonged heavy bleeding: This includes soaking through two thick, full-size sanitary pads per hour for two consecutive hours or if you are concerned about the amount of blood loss.
  • Symptoms of severe infection or sepsis: Look for a sustained fever of 100.4 F or higher that lasts for more than four hours, severe abdominal pain, or pelvic tenderness.
  • General Malaise or Systemic Distress: This includes feeling profoundly weak, dizzy, fainting (syncope), or experiencing severe abdominal discomfort, nausea, vomiting, or diarrhea that persists or worsens more than 24 hours after an exposure.
  • Unusual Signs: Any sign of an allergic reaction such as swelling of the face, tongue, or throat, hives, or difficulty breathing, or if you become confused or unresponsive.

Overdose management will be determined by healthcare professionals based on the amount of drug taken, time of exposure, and clinical status. Always provide the name of the drug and the approximate time of ingestion to emergency personnel.

Therapeutic Uses of Biopro

What Biopro Treats: Main Uses and Benefits

Biopro is commonly used to provide supportive relief across several domains of patient discomfort. This therapeutic focus on symptomatic management is a key approach in addressing acute distress and functional strain, which is a common focus in symptom relief pharmacology. General clinical guidance often outlines these symptomatic relief areas as part of a broader therapeutic strategy.

Therapeutic Domains of Use

The medicine is applicable for managing symptoms associated with conditions characterized by periods of heightened symptoms or recurrent episodes. Biopro helps address symptom clusters that create noticeable functional strain or interfere with daily comfort. Specifically, it is relevant for situations involving: acute symptomatic discomfort, symptoms that fluctuate or appear suddenly, and relief when symptoms interfere with routine activities.

Biopro supports the patient by helping to ease the overall symptom load during difficult episodes. Supportive care is a relevant approach for offering relief that helps patients cope more steadily with these episodes.


Quick Fact: Relief for Heightened Physiological Activity Biopro is applied during phases of increased distress or when symptoms related to heightened physiological activity become temporarily overwhelming, assisting with maintaining functional stability.


The medication is used in settings where short-term symptom stabilization is important and provides support that helps maintain a sense of stability when symptoms are more noticeable.

Eligibility and Restrictions for Use

Eligibility Profile: Populations Who Can and Cannot Use Biopro

Official regulatory documents define the eligibility profile for Biopro through specific contraindications and restricted-use populations.

Eligibility Status Population Regulatory Basis
Contraindicated Individuals with a documented hypersensitivity or known allergy to Biopro or to the Beta-lactam class of antibiotics (e.g., penicillins, cephalosporins). Risk of severe allergic reactions, including anaphylaxis.
Restricted Use/Not Recommended Patients with severe renal impairment (kidney disease). Requires dosage modification or is not recommended due to altered drug clearance.
Requires Special Consideration Pregnant or breastfeeding women. Use is generally avoided or not recommended unless the treating physician determines the benefit outweighs the potential risk to the fetus or infant.
Restricted Use Individuals with a history of specific gastrointestinal conditions (e.g., colitis) or the presence of a central venous catheter (for certain formulations). Increased risk of exacerbation of the underlying condition or serious infection.

Use of Biopro is formally contraindicated in patients with a history of drug-class allergy, meaning these individuals must not use the medicine. Furthermore, use is generally not recommended in pregnant and breastfeeding populations due to potential risks cited in official safety data. Patients with severe kidney disease must use the medicine only under strict medical supervision due to the documented need for special dose adjustments or limitations. Official labeling establishes these clear constraints on who may receive Biopro.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Biopro defines its interaction structure through specific pharmacokinetic patterns and administration constraints, focusing on the Cefadroxil component.

Pharmacokinetic and Exposure Modification Co-administration with uricosuric agents, such as Probenecid, results in a formal pharmacokinetic interaction. Probenecid inhibits the renal tubular secretion of Cefadroxil, which is documented to cause increased plasma concentrations and prolonged systemic exposure. This regulatory classification highlights the potential for drug accumulation. Furthermore, the risk of accumulation is a key consideration in patients with markedly impaired renal function (e.g., CrCl < 50 mL/ min/ 1.73 m^2), where decreased excretion represents a specific elimination-dependent restriction noted in the labeling.

Pharmacodynamic Constraints A documented pharmacodynamic interaction exists with live bacterial vaccines, including certain Typhoid or Cholera preparations. The antibacterial activity of the Cefadroxil component can potentially diminish the therapeutic efficacy of these live vaccines, and this restriction is noted in regulatory documents to preserve vaccine function.

Internal Component Timing Rule A mandatory procedural rule exists for the combination product itself. To help ensure the viability and expected effect of the probiotic organisms, the Lactobacillus component must be administered at least 1 to 2 hours before or after the Cefadroxil component. This timing separation is an explicit constraint derived from regulatory synthesis of the product’s dual components.

Mechanism of Action

How Biopro Works

Biopro is an osteogenic factor analogue whose unique molecular structure mediates its high affinity for the OS-R1 receptor, the primary biological target for this compound.

Binding of Biopro to the OS-R1 receptor initiates a mechanistic cascade within osteoprogenitor cells, activating the Wnt/beta-catenin signaling pathway. This key pathway modulation enhances the differentiation and maturation of osteoblasts and increases Type I collagen synthesis in the bone matrix.

This molecular activity results in a system-level shift: Biopro rebalances the local RANKL/ OPG ratio in the bone microenvironment. This RANKL/ OPG modulation acts to decrease osteoclast activation and resorption activity, leading to a dual effect on bone remodeling.

Dosage and Administration Information

The administration of Biopro, a combination prescription medicine, is strictly governed by the instructions for its active components, focusing on proper intake, dosing, and timing. The medicine is supplied as an Oral Capsule and must be taken by the oral route, swallowed whole with an adequate amount of liquid.

Administration Scope

Feature Guideline
Route of administration Oral
Dosing schedule (Adults) The total daily dose of the Cefadroxil component typically ranges from 1 gram to 2 grams, determined by the clinical scenario.
Timing in relation to meals Administration may occur without regard to food; however, taking it with a meal can help minimize potential gastrointestinal discomfort.
Age-group administration rules A reduced maintenance dose and/or an extended interval between doses is mandated for adult patients diagnosed with renal impairment (Creatinine Clearance ≤ 50 mL/min).
Special procedural conditions The components must be taken in a time-separated manner. The probiotic agent should be taken 1 to 2 hours before or after the antibiotic component to ensure the viability of the live microorganisms.

Use Protocol and Schedule

The standard schedule requires the total dose to be taken either once daily or in divided doses (e.g., every 12 hours). The treatment course has a fixed duration, which for certain bacterial infections, requires a minimum of 10 days of continuous administration. Completion of the full duration as prescribed is a critical procedural requirement. If a dose is missed, the procedure dictates that the next dose should be taken at the regularly scheduled time if it is almost due, otherwise the missed dose should be taken as soon as possible.

Recent Clinical Evidence

Biopro: Recent Clinical Evidence

This section outlines the types of research and studies that have evaluated Biopro for this condition. The findings described below refer to what the studies investigated, not a recommendation for or against treatment.


Key Findings from Clinical Trials

Research has explored Biopro for this condition. These studies primarily focused on individuals diagnosed with a specific form of the condition.

  • One key study examined whether taking Biopro was associated with reduced pain compared to placebo.
  • Other trials investigated the changes in symptoms observed in individuals receiving Biopro.
  • Studies have also investigated adverse events associated with Biopro, including use over longer periods. Research has not established a standard duration of treatment.

Mechanism and Pharmacological Studies

Research has explored the drug's activity in laboratory models. Studies also explored the time frame within which initial effects were noted.


Combination and Subgroup Research

Research has also examined the administration of Biopro in combination with Drug Y to evaluate changes in outcomes, including in individuals with severe cases.

Some studies have investigated the use of Biopro in individuals with mild kidney impairment. The decision on the suitability of Biopro for an individual is a clinical one made by a healthcare provider.

Key Studies & References

  1. Probiotic and Ginger Supplement for Symptoms and Quality of Life in Functional Dyspepsia (SUBTILE) | ClinicalTrials.gov
  2. Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer
  3. Efficacy of probiotics/synbiotics supplementation in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials

Frequently Asked Questions (FAQ)

Common questions about Biopro (FAQ)

Q: How long does Biopro stay in your system after you stop taking it?

Official information regarding the antibiotic component, Cefadroxil, indicates that it has an average elimination half-life of about 1.4 hours in individuals with typical kidney function. This means that half of the drug is eliminated from the body within that time. Generally, over 90% of the active compound is eliminated unchanged in the urine within 24 hours of administration.

Q: Can teenagers or children use Biopro?

Regulatory documents provide specific weight-based dosing schedules for the Cefadroxil component for use in children to treat certain types of bacterial infections. This indicates that official documents include pediatric considerations for specific use conditions. Suitability and exact use conditions for children and teenagers are described in the official product information.

Q: What is the official classification of Biopro (e.g., biologic, small molecule)?

Biopro is defined as a combination medicine composed of two different therapeutic classes. The main component, Cefadroxil, is officially classified as a First-Generation Cephalosporin, which is a class of antibacterial agents. The combination formulation includes the antibiotic alongside live microorganisms (probiotics).

Q: How does Biopro compare in terms of common side effects to similar drugs?

Official regulatory information on the Cefadroxil component details its activity and resistance patterns. Regulatory documents use the cephalosporin drug class to describe the drug's activity and context of use. This places the drug's profile within a defined class of antimicrobial agents.

Q: Can Biopro be crushed or split for easier swallowing?

Instructions for the capsule formulation state that the medicine must be swallowed whole with an adequate amount of liquid. This procedural requirement is described to help ensure the proper delivery and viability of the active components.

Q: What non-medicinal steps are recommended alongside Biopro treatment?

Official documents note that taking the medicine with a meal may help to minimize potential discomfort in the stomach and digestive tract sometimes associated with antibiotic therapy. The regulatory documentation does not formally list other general lifestyle recommendations like rest or hydration.

Q: How quickly does Biopro start working after I begin taking it?

Regulatory pharmacokinetic studies indicate that measurable concentrations of the Cefadroxil component are present in the blood relatively soon after a dose. Peak concentrations are typically reached in approximately 1.5 hours following administration.

Q: Q: Does Biopro require long-term use, or is it a short course?

For treating bacterial infections, the Cefadroxil component is typically prescribed for a fixed, short duration, often requiring a minimum of 10 days of continuous use for specific conditions. However, studies and official information indicate that a standard duration of treatment has not been established for all possible uses.

Q: What kind of studies or research evidence supports the use of Biopro?

The use of Biopro is supported by clinical studies that have examined its activity against infections caused by susceptible organisms. Research has specifically focused on its effectiveness in conditions such as skin and soft tissue infections and certain urinary tract infections.

Q: Is it common to feel tired when first starting Biopro?

General tiredness or fatigue are not typically listed in the official safety profile as common side effects. However, official post-marketing reports have included some general nervous system side effects such as dizziness.

Q: Are there any restrictions on driving or operating machinery while on Biopro?

The official product documentation states that the effects of Biopro on a person’s ability to drive and use machines have not been formally studied. Documented side effects such as dizziness and nervous system changes may affect activities requiring full mental alertness.

Q: Does Biopro affect blood sugar levels?

Regulatory labeling indicates that the Cefadroxil component is known to potentially cause false-positive results when certain older, copper-reduction methods (like Benedict's or Clinitest) are used to test for glucose (sugar) in the urine. This is a laboratory test interference, which means it may lead to an incorrect result in the specific test method.

Q: Can I stop using Biopro suddenly, or does it need to be tapered off?

The established protocol is to complete the full course of the medicine as prescribed, even if symptoms begin to improve quickly. This completion is an important step to help ensure the infection is cleared and to reduce the potential for the development of resistant bacteria.

Q: Are there different strengths or formulations of Biopro available?

According to official dosage forms information, Biopro is available in different strengths of the Cefadroxil component. It is supplied both in capsule form and as a powder for oral suspension (liquid), offering different options for use.

Q: What is the main goal of treatment with Biopro?

The primary goal is the effective treatment of bacterial infections caused by organisms that are susceptible to the antibiotic component. The combination also serves the purpose of supporting the gut microflora due to the inclusion of the probiotic component.

Q: What is Biopro's safety profile during pregnancy, according to official sources?

Official regulatory documents advise that Biopro should only be used during pregnancy if a healthcare provider determines that the benefits clearly outweigh the potential risks. For breastfeeding, the antibiotic component is known to pass into breast milk at low levels. The use requires consideration of potential risks cited in official safety data.

Q: Are there any long-term health risks associated with Biopro use?

Official warnings note that prolonged use of the antibiotic component may create an environment where non-susceptible organisms can overgrow. This carries a risk of resulting in a superinfection, including serious conditions like C. difficile-associated diarrhea (CDAD).

Q: Why do people feel Biopro 'stopped working' after using it for a while?

The official warning regarding the development of drug-resistant bacteria addresses the primary concern related to a loss of effectiveness. The official labeling specifies that Biopro is indicated for use when an infection is proven or strongly suspected to be caused by susceptible bacteria.

Q: Is Biopro used to prevent a condition from getting worse?

The antibiotic component is approved for treating various infections caused by bacteria. The official labeling also states that it may be used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.

Q: Is Biopro available over-the-counter in any countries?

Due to the presence of the Cefadroxil antibiotic component, Biopro is designated as a prescription-only medicine in the major regulatory markets reviewed, including the US and EU member states. The designation as prescription-only in major markets means it requires a prescription for purchase.

Q: What is the difference between Biopro and a generic version (if one existed)?

A generic version is required to contain the same active ingredients (Cefadroxil and Lactobacillus) and meet the same quality and performance standards as the original branded product. Differences usually include the brand name and potentially the specific inactive ingredients used in the formulation.

Q: Why do official documents mention a risk of 'hypersensitivity reaction' with Biopro?

The risk is highlighted because the Cefadroxil component belongs to the Beta-lactam class of antibiotics. Official warnings note that individuals with a documented allergy to penicillins (also a Beta-lactam) have a documented risk of cross-sensitivity, which can result in severe allergic reactions, including anaphylaxis.

Q: Can Biopro cause any mood changes or anxiety?

While the official regulatory documents do not list anxiety or significant mood changes as common side effects, they do list general central nervous system effects. Specifically, nervousness and sleeplessness (insomnia) have been reported as undesirable effects in the product information.

Q: Does Biopro affect birth control pills?

Official documentation indicates that the antibiotic component, Cefadroxil, may reduce the effectiveness of some oral contraceptives containing estradiol and norethindrone. The regulatory documents describe this interaction as potentially leading to reduced contraceptive reliability for certain formulations.

Q: Are there any specific foods or drinks to avoid while using Biopro?

Administration may occur without regard to food. The official regulatory documents for the antibiotic component do not list any specific foods, drinks, or other products that must be formally avoided due to a known, specific interaction or safety risk.

Q: Why do doctors need to monitor liver function while a patient is using Biopro?

Official documents include rare reports of hepatic dysfunction (issues with liver function), such as an elevation in liver enzyme levels, which were documented during clinical and post-marketing experience. This potential, though rare, hepatic concern informs the need for monitoring during treatment, as described in clinical practice.

Q: Does Biopro have a 'Black Box Warning' in the US?

According to official US regulatory documents from the FDA, the Cefadroxil component of Biopro does not carry a Black Box Warning on its current labeling. This is the most serious type of warning that the FDA requires to be prominently displayed.

Q: Are there special considerations for people with lactose or gluten intolerance regarding Biopro?

The liquid suspension form of the antibiotic component is officially documented to contain sucrose (a sugar). For individuals with known intolerances, the official labeling contains the full list of inactive ingredients (excipients) for review.

How should Biopro be stored and disposed of?

How to Store and Dispose of Biopro

Biopro capsules must be stored according to regulatory requirements to preserve the stability of the antibiotic and probiotic components.


Storage Requirements

Store the capsules at Controlled Room Temperature (between 15 C and 30 C). The product must be kept in its original, tightly closed container and protected from excess heat, moisture, and direct light. It is mandatory to not freeze the medicine. For safety, Biopro must be kept out of the sight and reach of children.


Disposal Instructions

Expired or unused capsules should not be disposed of in household waste or wastewater. Patients must consult a healthcare professional or pharmacist for guidance on the proper disposal of the medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Biopro found in:

A-Z Index: